ASA-BUTALB-CAFF-COD #3 CAPSULE

What it is

ASA-BUTALB-CAFF-COD #3 CAPSULE is how the CMS NADAC file names this product. The FDA NDC Directory lists it as butalbital, aspirin, caffeine and codeine phosphate.

FDA gives its dosage form as capsule and its route as oral.

The labeler, the company named on the label, is Amneal Pharmaceuticals of New York, LLC.

FDA lists it under 6 Established Pharmacologic Classes: Barbiturate, Central Nervous System Stimulant, Methylxanthine, Nonsteroidal Anti-inflammatory Drug, Opioid Agonist and Platelet Aggregation Inhibitor.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 69238-1993-01.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $30.12 for 30 capsules (30 × $1.00389 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

What NADAC measures · Why 30 capsules · NADAC explanation codes

The NDC

• 69238-1993-01 · Amneal Pharmaceuticals of New York, LLC · $1.00389 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

1 other product in the NADAC file shares the FDA nonproprietary name butalbital, aspirin, caffeine and codeine phosphate with ASA-BUTALB-CAFF-COD #3 CAPSULE.

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

Its NADAC price is $1.00389 per EA filed.

Of the 10 other products in FDA’s Barbiturate class priced per EA, 3 have a higher middle NADAC price and 6 a lower one; 1 has the same. The one in the middle is BUTALBITAL-ACETAMINOPHEN 50-300 MG TAB, at $0.87462 per EA filed (eff. 2026-09-23).

Of the 203 other products in FDA’s Central Nervous System Stimulant class priced per EA, 149 have a higher middle NADAC price and 53 a lower one; 1 has the same. The one in the middle is FOCALIN XR 5 MG CAPSULE, at $4.70352 per EA filed (eff. 2026-09-23).

Of the 32 other products in FDA’s Methylxanthine class priced per EA, 9 have a higher middle NADAC price and 22 a lower one; 1 has the same. The one in the middle is QC STAY AWAKE 200 MG TABLET, at $0.08299 per EA filed (eff. 2026-09-23).

Of the 154 other products in FDA’s Nonsteroidal Anti-inflammatory Drug class priced per EA, 28 have a higher middle NADAC price and 125 a lower one; 1 has the same. The one in the middle is INDOMETHACIN 25 MG CAPSULE, at $0.09341 per EA filed (eff. 2026-09-23).

Of the 108 other products in FDA’s Opioid Agonist class priced per EA, 50 have a higher middle NADAC price and 57 a lower one; 1 has the same. The one in the middle is BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-325-40-30 MG CP, at $0.79784 per EA filed (eff. 2026-09-23).

Of the 35 other products in FDA’s Platelet Aggregation Inhibitor class priced per EA, 0 have a higher middle NADAC price and 34 a lower one; 1 has the same. The one in the middle is SM ASPIRIN 81 MG CHEWABLE TAB, at $0.02571 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

We don’t know yet; the card above says why.

Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

• What is your cash price for 30 capsules? Is it lower than what I would pay through my insurance?
• These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.